A recently validated polygenic risk score (PRS) is independently associated with prevalent peripheral artery disease (PAD) and incidence of major adverse limb events (MALE) in cardiometabolic patients.
Each standard deviation increase in PRS confers a 15% higher odds of prevalent PAD and a 30% increased risk of MALE, comparable to established clinical risk factors.
Incorporating the PAD PRS with clinical variables modestly improves risk discrimination for MALE but may have limited immediate clinical utility.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
